Inozyme Pharma, Inc.
NasdaqGS:INZY
$ 4.40
$0.00 (0.00%)
$ 4.40
$0.00 (0.00%)
End-of-day quote: 04/24/2024

INZY - Inozyme Pharma Stock Prediction 2025 - 2030

4 years of reliable Inozyme Pharma stock forecast. The Wall Street analysts predict Buy for INZY. See at a glance whether NasdaqGS:INZY will rise in the future.

$0.00
Forecast 2023
$5.27
Forecast 2025
$8.95
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$5.27
Forecast 2030
$8.95
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.37
Price-to-book Ratio
1.94
Market Cap
0.35B
TEV
0.04 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$21.00

Inozyme Pharma Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Inozyme Pharma Stock Forecast 2023

$15.50

In the last five quarters, Inozyme Pharma’s Price Target has risen from $20.74 to $21.00 - a 1.25% increase. Seven analysts predict that Inozyme Pharma’s share price will fall in the coming year, reaching $15.50. This would represent a decrease of -26.19%.

252.27%
252.27
Last update: 04/25/2024

Highest Price Target $40.00

Average Price Target $15.50

Lowest Price Target $14.00

Inozyme Pharma Stock Predictions 2025

Stock Forecast for the Price of an Inozyme Pharma Share in Jan 2025.

In January 2025, analysts believe the stock price will be $4.78. An increase of 8.64% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in Feb 2025.

In February 2025, analysts believe the stock price will be $4.82. An increase of 9.64% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in Mar 2025.

In March 2025, analysts believe the stock price will be $4.87. An increase of 10.64% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in Apr 2025.

In April 2025, analysts believe the stock price will be $4.91. An increase of 11.65% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in May 2025.

In May 2025, analysts believe the stock price will be $4.96. An increase of 12.65% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in Jun 2025.

In June 2025, analysts believe the stock price will be $5.00. An increase of 13.66% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in Jul 2025.

In July 2025, analysts believe the stock price will be $5.04. An increase of 14.66% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in Aug 2025.

In August 2025, analysts believe the stock price will be $5.09. An increase of 15.66% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in Sep 2025.

In September 2025, analysts believe the stock price will be $5.13. An increase of 16.67% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in Oct 2025.

In October 2025, analysts believe the stock price will be $5.18. An increase of 17.67% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in Nov 2025.

In November 2025, analysts believe the stock price will be $5.22. An increase of 18.67% compared to the previous month's estimate.

Stock Forecast for the Price of an Inozyme Pharma Share in Dec 2025.

In December 2025, analysts believe the stock price will be $5.27. An increase of 19.68% compared to the previous month's estimate.

Inozyme Pharma Stock Prediction 2030

Stock Prediction for the Price of One Inozyme Pharma Share in Jan 2030.

In Jan 2030 analysts predict a share price of $8.12. An increase of 84.63% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in Feb 2030.

In Feb 2030 analysts predict a share price of $8.20. An increase of 86.34% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in Mar 2030.

In Mar 2030 analysts predict a share price of $8.27. An increase of 88.04% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in Apr 2030.

In Apr 2030 analysts predict a share price of $8.35. An increase of 89.75% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in May 2030.

In May 2030 analysts predict a share price of $8.42. An increase of 91.45% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in Jun 2030.

In Jun 2030 analysts predict a share price of $8.50. An increase of 93.16% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in Jul 2030.

In Jul 2030 analysts predict a share price of $8.57. An increase of 94.87% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in Aug 2030.

In Aug 2030 analysts predict a share price of $8.65. An increase of 96.57% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in Sep 2030.

In Sep 2030 analysts predict a share price of $8.72. An increase of 98.28% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in Oct 2030.

In Oct 2030 analysts predict a share price of $8.80. An increase of 99.98% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in Nov 2030.

In Nov 2030 analysts predict a share price of $8.87. An increase of 101.69% compared to today's share price.

Stock Prediction for the Price of One Inozyme Pharma Share in Dec 2030.

In Dec 2030 analysts predict a share price of $8.95. An increase of 103.39% compared to today's share price.

P/E
0.00
Beta
1.37
Price-to-book Ratio
1.94
Market Cap
0.35B
TEV
0.04 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$21.00

Inozyme Pharma Analyst Ratings Frequently Asked Questions

Who are the analysts watching Inozyme Pharma, Inc.?

The following analysts have recently covered Inozyme Pharma:

BofA Global Research
H.C. Wainwright & Co.
Jefferies LLC
Needham & Company
Piper Sandler Companies
TD Cowen
Wedbush Securities Inc.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Inozyme Pharma, Inc.?

The following sell-side analysts have recently covered Inozyme Pharma:

Ahmad, Tazeen
White, Edward Patrick
Tejavibulya, Nalin
Stringer, Joseph Robert
Raymond, Christopher Joseph
Frahm, Marc Alan
Nierengarten, David Matthew
(This information refers to the last 90 days.)